AGAR CHROMID CARBA (CARB) - INVIMA Registration d3815b95f74bc5f17b935f26f69e102d
Access comprehensive regulatory information for AGAR CHROMID CARBA (CARB) (AGAR CHROMID CARBA (CARB)) in the Colombia medical device market through Pure Global AI's free database. This I medical device is registered under INVIMA analysis ID d3815b95f74bc5f17b935f26f69e102d and manufactured by BIOMERIEUX S.A.. The device was registered on December 05, 2032.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
MEDIO CROMOGÉNICO SELECTIVO PARA EL CRIBADO DE_x000D_ ENTEROBACTERIACEAE PRODUCTORAS DE _x000D_ CARBAPENEMASA (EPC). ESTE MEDIO ES UN MEDIO _x000D_ CROMOGÉNICO SELECTIVO PARA EL CRIBADO DE _x000D_ ENTEROBACTERIACEAE PRODUCTORAS DE _x000D_ CARBAPENEMASA (EPC), ESPECIALMENTE KPC Y NDM-1, EN _x000D_ PACIENTES PORTADORES CRÓNICOS O EN PACIENTES EN _x000D_ RIESGO. ESTE MEDIO NO ES UN SUSTITUTO DE LOS _x000D_ MÉTODOS CONVENCIONALES DE LAS PRUEBAS DE _x000D_ SENSIBILIDAD ANTIMICROBIANA. LAS EPC SON BACTERIAS _x000D_ ESPECIALMENTE MULTIRRESISTENTES CAPACES DE _x000D_ CAUSAR INFECCIONES NOSOCOMIALES Y EPIDEMIAS_x000D_ HOSPITALARIAS.3,4 LA DETECCIÓN DE LOS PORTADORES _x000D_ DE EPC ES PARTICULARMENTE IMPORTANTE EN LA _x000D_ PREVENCIÓN Y LA SUPERVISIÓN EPIDEMIOLÓGICA DE _x000D_ ESTAS INFECCIONES. EN ESTE CONTEXTO, EL USO DEL _x000D_ AGAR CHROMID® CARBA CONTRIBUYE A LA VIGILANCIA_x000D_ ACTIVA DE LAS EPC._x000D_
SELECTIVE CHROMOGENIC MEDIUM FOR DE_x000D_ SCREENING ENTEROBACTERIACEAE PRODUCING _x000D_ CARBAPENEMASE (EPC). THIS MEDIUM IS A MEDIUM _x000D_ CHROMOGENIC SELECTIVE FOR _x000D_ SCREENING ENTEROBACTERIACEAE PRODUCING _x000D_ CARBAPENEMASE (EPC), ESPECIALLY KPC AND NDM-1, IN _x000D_ CHRONIC CARRIER PATIENTS OR IN PATIENTS IN _x000D_ RISK. THIS MEDIUM IS NOT A SUBSTITUTE FOR _x000D_ CONVENTIONAL METHODS OF _x000D_ TESTING ANTIMICROBIAL SENSITIVITY. PCES ARE BACTERIA _x000D_ ESPECIALLY MULTI-RESISTANT CAPABLE OF _x000D_ CAUSE NOSOCOMIAL INFECTIONS AND EPIDEMIAS_x000D_ HOSPITAL.3,4 DETECTION OF CARRIERS _x000D_ OF EPC IS PARTICULARLY IMPORTANT IN THE _x000D_ PREVENTION AND EPIDEMIOLOGICAL SURVEILLANCE OF _x000D_ THESE INFECTIONS. IN THIS CONTEXT, THE USE OF _x000D_ AGAR CHROMID® CARBA CONTRIBUTES TO THE VIGILANCIA_x000D_ ACTIVE EPC._x000D_